US OptionsDetailed Quotes
OCGN241220C1500
- 0.03
- 0.000.00%
15min DelayClose Nov 22 15:59 ET
0.00High0.00Low
0.03Open0.03Pre Close0 Volume760 Open Interest1.50Strike Price0.00Turnover155.55%IV68.69%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.1722Delta0.6536Gamma30.25Leverage Ratio-0.0018Theta0.0001Rho5.21Eff Leverage0.0006Vega
Ocugen Stock Discussion
Sign in to post a comment
$Ocugen (OCGN.US)$ buy dont sell
1
$Ocugen (OCGN.US)$ Reuters· 3 mins ago
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
1
$Ocugen (OCGN.US)$ Reuters· just
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
1
1
$Ocugen (OCGN.US)$ it exceeded estimates for these few quarters
$Ocugen (OCGN.US)$ price manipulation
$Ocugen (OCGN.US)$ no sell button
1
$Ocugen (OCGN.US)$ let's goooo
2
No comment yet
GERMAN APE OP : Great News!